GDF-15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR Program

被引：0
|
作者：
Ferreira, J. P. [1 ]
Sumin, M. [2 ]
Masson, S. [3 ]
Zannad, F. [1 ]
机构：
[1] Univ Lorraine, Nancy, France
[2] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[3] Roche Diagnost Int Ltd, Rotkreuz, Switzerland
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：292 / 292
页数：1
相关论文
共 50 条
  • [21] Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme
    Zannad, Faiez
    Ferreira, Joao Pedro
    Butler, Javed
    Filippatos, Gerasimos
    Januzzi, James L.
    Sumin, Mikhail
    Zwick, Matthias
    Saadati, Maral
    Pocock, Stuart J.
    Sattar, Naveed
    Anker, Stefan D.
    Packer, Milton
    EUROPEAN HEART JOURNAL, 2022, 43 (48) : 4991 - 5002
  • [22] Towards a multi-marker prognostic strategy in acute heart failure: a role for GDF-15
    Bettencourt, Paulo
    Ferreira-Coimbra, Joao
    Rodrigues, Pedro
    Marques, Pedo
    Moreira, Helena
    Pinto, Maria Joao
    Guimaraes, Joao Tiago
    Lourenco, Patricia
    ESC HEART FAILURE, 2018, 5 (06): : 1017 - 1022
  • [23] GDF-15 in heart failure: providing insight into end-organ dysfunction and its recovery?
    Wollert, Kai C.
    Kempf, Tibor
    EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (11) : 1191 - 1193
  • [24] Prognostic role of growth differentiation factor 15 (GDF-15) in obese patients with systolic heart failure (HF)
    Benes, J.
    Kotrc, M.
    Melenovsky, V.
    Kautzner, J.
    Jarolim, P.
    EUROPEAN HEART JOURNAL, 2015, 36 : 841 - 841
  • [25] GDF-15 and sST2 as biomarkers for arrhythmic death in non ischemic heart failure
    Demyanets, S.
    Stojkovic, S.
    Kaider, A.
    Koller, L.
    Brekalo, M.
    Diedrich, A.
    Wojta, J.
    Pezawas, T.
    CARDIOVASCULAR RESEARCH, 2018, 114 : S30 - S30
  • [26] EMPAGLIFLOZIN AND SERUM POTASSIUM IN HEART FAILURE: AN ANALYSIS FROM EMPEROR-POOLED
    Ferreira, Joao Pedro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 312 - 312
  • [27] Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
    Ferreira, Joao Pedro
    Zannad, Faiez
    Butler, Javed
    Filipattos, Gerasimos
    Ritter, Ivana
    Schuler, Elke
    Kraus, Bettina J.
    Pocock, Stuart J.
    Anker, Stefan D.
    Packer, Milton
    EUROPEAN HEART JOURNAL, 2022, 43 (31) : 2984 - 2993
  • [28] Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study
    Cotter, Gad
    Voors, Adriaan A.
    Prescott, Margaret F.
    Felker, G. Michael
    Filippatos, Gerasimos
    Greenberg, Barry H.
    Pang, Peter S.
    Ponikowski, Piotr
    Milo, Olga
    Hua, Tsushung A.
    Qian, Min
    Severin, Thomas M.
    Teerlink, John R.
    Metra, Marco
    Davison, Beth A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (11) : 1133 - 1143
  • [29] Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis
    Zimmers, Teresa A.
    Jin, Xiaoling
    Gutierrez, Juan C.
    Acosta, Cary
    McKillop, Iain H.
    Pierce, Robert H.
    Koniaris, Leonidas G.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (07) : 753 - 759
  • [30] Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis
    Teresa A. Zimmers
    Xiaoling Jin
    Juan C. Gutierrez
    Cary Acosta
    Iain H. McKillop
    Robert H. Pierce
    Leonidas G. Koniaris
    Journal of Cancer Research and Clinical Oncology, 2008, 134 : 753 - 759
12345